aTyr Pharma
aTyr Pharma's Overview
aTyr Pharma, Inc. is a clinical-stage biotherapeutics company dedicated to the discovery and development of innovative, first-in-class medicines based on novel immunological pathways. The company's research and development efforts are centered on a newly discovered area of biology involving extracellular protein synthesis and the Resokine pathway. aTyr's lead therapeutic candidate is efzofitimod (ATYR1923), a modulator of neuropilin-2 (NRP2) that is currently being evaluated in clinical trials for patients with pulmonary sarcoidosis, a major form of interstitial lung disease. aTyr Pharma aims to leverage its proprietary platform to deliver transformative therapies for patients with severe, rare immune-mediated diseases with high unmet medical needs.
Where is aTyr Pharma's Headquarters?
HQ Function
Serves as the central hub for corporate administration, research and development activities, clinical operations, and strategic planning.
Notable Features:
Modern laboratory and office facilities equipped for biopharmaceutical research and development. Located within a prominent biotech park, facilitating collaboration and access to talent.
Work Culture:
Fosters a collaborative, innovative, and science-driven work environment focused on advancing novel therapies for patients. Emphasizes teamwork, scientific rigor, and a commitment to addressing unmet medical needs.
HQ Significance:
The San Diego location provides aTyr Pharma with access to a rich ecosystem of research institutions, skilled scientific talent, and venture capital, crucial for its growth and development in the competitive biotech landscape.
Values Reflected in HQ: The headquarters' focus on R&D facilities reflects aTyr's core values of scientific innovation, patient-centricity, and the pursuit of breakthrough therapies.
Location:
While headquartered in the US, aTyr Pharma's clinical development programs, particularly for efzofitimod, involve collaborations and trial sites internationally, reflecting a global approach to research and patient reach. Their partnerships and scientific collaborations may also extend globally to advance their understanding of the Resokine pathway and develop new therapies.
Street Address:
3545 John Hopkins Court, Suite #250
City:
San Diego
State/Province:
CA
Country:
USA
aTyr Pharma's Global Presence
Buying Intent Signals for aTyr Pharma
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of aTyr Pharma
As of April 2025, aTyr Pharma' leadership includes:
Investors of aTyr Pharma
aTyr Pharma has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
In the past year (May 2023 - May 2024), aTyr Pharma strengthened its executive leadership with the key appointment of Jill M. Church as Chief Financial Officer. Other core C-suite leadership positions appear stable based on public announcements.
New Appointments:
Technology (Tech Stack) used by aTyr Pharma
Discover the tools aTyr Pharma uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
aTyr Pharma Email Formats and Examples
aTyr Pharma likely utilizes common corporate email formats. A frequently observed pattern for the company is the first initial followed by the last name.
[first_initial][last]@atyrpharma.com
Format
sshukla@atyrpharma.com
Example
75%
Success rate
News and media
GlobeNewswire • May 2, 2024
aTyr Pharma Reports First Quarter 2024 Results and Provides Corporate Update
aTyr Pharma announced its financial results for the first quarter ended March 31, 2024, highlighting progress in its efzofitimod clinical program for pulmonary sarcoidosis, including patient enrollment milestones for the global EFZO-FIT™ study....more
GlobeNewswire • April 2, 2024
aTyr Pharma to Present at the 23rd Annual Needham Virtual Healthcare Conference
aTyr Pharma announced its participation and presentation at the 23rd Annual Needham Virtual Healthcare Conference, providing an update on its corporate strategy and clinical development programs....more
GlobeNewswire • March 5, 2024
aTyr Pharma Reports Fourth Quarter and Full Year 2023 Results and Provides Corporate Update
aTyr Pharma reported its financial results for the fourth quarter and full year 2023, detailing advancements in the efzofitimod program and outlining key objectives for 2024....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including aTyr Pharma, are just a search away.